Mariner Wealth Advisors (NYC)’s Amgen AMGN Stock Holding History

Mariner Wealth Advisors (NYC)’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$155K	Buy	+969	New	+$153K	0.07%	73

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Mariner Wealth Advisors (NYC)'s AMGN Position: Q1 2015 in Review

Mariner Wealth Advisors (NYC) opened a new position in Amgen (AMGN) in Q1 2015: 969 shares worth $155K. The stake represents 0.07% of the portfolio and ranks #73 among its holdings.

1,345 funds tracked by Wall St. Rank hold AMGN as of Q1 2015.

Mariner Wealth Advisors (NYC) held 969 shares of Amgen worth $155K as of Q1 2015.
Amgen was a new Mariner Wealth Advisors (NYC) position in Q1 2015.
Amgen made up 0.07% of Mariner Wealth Advisors (NYC)'s portfolio in Q1 2015, its #73 holding.
1,345 funds tracked by Wall St. Rank held Amgen as of Q1 2015.

Based on Mariner Wealth Advisors (NYC)'s 13F filing for Q1 2015, filed 14 May 2015.